PuSH - Publikationsserver des Helmholtz Zentrums München

Export: TXT Text RIS Endnote (RIS) BIB BibTeX
Subklewe, M.*

Dendritic cells for the induction of EBV immunity.

Recent Results Cancer Res. 159, 38-43 (2002)
PMC
Open Access Green möglich sobald Postprint bei der ZB eingereicht worden ist.
Cell-mediated immunity provides resistance to Epstein-Barr virus (EBV), as demonstrated by the occurrence of EBV-induced post-transplant lymphoproliferative disease (PTLPD) in immunosuppressed patients. T cell immunity is stimulated most effectively by dendritic cells (DCs). Although DCs are not direct targets for infection by EBV, we tested whether EBV antigens are cross-presented by human DCs and whether DCs are efficient at stimulation of EBV-specific CD8+ T cells. We show that DCs cross-presenting apoptotic or necrotic lymphoblastoid cell lines (LCLs) are able to expand CD8+ T cells that directly recognize HLA-matched LCLs by IFN-gamma secretion and cytolytic activity. Part of this EBV-specific CD8+ T cell response was specific for the EBV nuclear antigen EBNA3 A and the latent membrane protein LMP2a. Both these antigens are expressed in PTLPD. In other EBV-associated malignancies such as Hodgkin' s lymphoma, T cell lymphoma and nasopharyngeal carcinoma, LMP2a is maintained. Therefore, the cross-presenting ability of DCs might be explored in DC-mediated active immunization against EBV-associated malignancies.
Impact Factor
Scopus SNIP
Altmetric
0.000
0.000
Tags
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern

Zusatzinfos bearbeiten
Eigene Tags bearbeiten
Privat
Eigene Anmerkung bearbeiten
Privat
Auf Publikationslisten für
Homepage nicht anzeigen
Als besondere Publikation
markieren
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
Sprache englisch
Veröffentlichungsjahr 2002
HGF-Berichtsjahr 0
ISSN (print) / ISBN 0080-0015
Zeitschrift Recent Results in Cancer Research
Quellenangaben Band: 159, Heft: , Seiten: 38-43 Artikelnummer: , Supplement: ,
Verlag Springer
Begutachtungsstatus Peer reviewed
Institut(e) Institute of Molecular Immunology (IMI)
PubMed ID 11785842
Erfassungsdatum 2002-12-31
[➜Korrektur melden]